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O B J E C T I V E S A prospective, multicenter 18ﬂuorine-ﬂuorodeoxyglucose (18F-FDG) positron emis-
sion tomography (PET)/computed tomography (CT) imaging study was performed to estimate the
correlations among arterial FDG uptake and atherosclerotic plaque biomarkers in patients with
peripheral artery disease.
B A C KG ROUND Inﬂammation within atherosclerotic plaques is associated with instability of the
plaque and future cardiovascular events. Previous studies have shown that 18F-FDG-PET/CT is able to
quantify inﬂammation within carotid artery atherosclerotic plaques, but no studies to date have
investigated this correlation in peripheral arteries with immunohistochemical conﬁrmation.
METHOD S Thirty patients across 5 study sites underwent 18F-FDG-PET/CT imaging before Silver-
Hawk atherectomy (FoxHollow Technologies, Redwood City, California) for symptomatic common or
superﬁcial femoral arterial disease. Vascular FDG uptake (expressed as target-to-background ratio) was
measured in the carotid arteries and aorta and femoral arteries, including the region of atherectomy.
Immunohistochemistry was performed on the excised atherosclerotic plaque extracts, and cluster of
differentiation 68 (CD68) level as a measure of macrophage content was determined. Correlations
between target-to-background ratio of excised lesions, as well as entire arterial regions, and CD68 levels
were determined. Imaging was performed during the 2 weeks before surgery in all cases.
R E S U L T S Twenty-one patients had adequate-quality 18F-FDG-PET/CT peripheral artery images, and
34 plaque specimens were obtained. No signiﬁcant correlation between lesion target-to-background
ratio and CD68 level was observed.
CONC L U S I O N S There were no signiﬁcant correlations between CD68 level (as a measure of
macrophage content) and FDG uptake in the peripheral arteries in this multicenter study. Differences in lesion
extraction technique, lesion size, the degree of inﬂammation, and imaging coregistration techniques may
have been responsible for the failure to observe the strong correlations with vascular FDG uptake observed
in previous studies of the carotid artery and in several animal models of atherosclerosis. (J Am Coll Cardiol
Img 2012;5:38–45) © 2012 by the American College of Cardiology Foundation
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39T
he association of atherosclerotic plaque in-
flammation with clinical cardiovascular events
(1) has sparked development of noninvasive
imaging modalities that can measure such
nflammation (2). Such techniques might improve
dentification of patients at risk of cardiovascular
vents and may be useful for monitoring therapeutic
esponses. The arterial uptake of 18fluorine-
uorodeoxyglucose (18F-FDG), measured by the
positron emission tomography (PET) component
of PET/computed tomography (CT), has shown
promise as a surrogate marker of arterial inflamma-
tion in the carotid arteries, vertebral arteries, and
aorta (3–8). It has been demonstrated that FDG
uptake correlates with levels of circulating inflam-
matory biomarkers (9), expression of inflammatory
genes (10), cardiovascular risk factors (9), and
localization of symptomatic plaques (4). Autoradio-
graphic examination of plaque after 18F-FDG-
ET/CT imaging has revealed that macrophages
ccount for the majority of FDG uptake (3,6,7).
owever, such studies have only been performed in
he carotid arteries.
Symptomatic peripheral artery atherosclerosis
ffects an estimated 8 million Americans (11),
ith a 5-year death rate of 30% attributed to
oexisting cardiovascular and cerebrovascular dis-
ase (12). FDG PET/CT imaging in peripheral
rteries, including the femoral arteries, has high
eproducibility (13). To date, there has been no
nvestigation of the cell type responsible for FDG
ptake in peripheral atherosclerosis. To investigate
his topic, we recruited patients with symptom-
tic peripheral artery disease (PAD) scheduled for
ercutaneous atherectomy. 18F-FDG-PET/CT im-
aging was performed before atherectomy, and
excised plaque samples were obtained for immu-
nohistochemistry. The primary objective was to
estimate the correlation between arterial FDG
uptake and the macrophage content of excised
plaque tissue. Secondary aims were to measure
correlations between lesional FDG uptake, FDG
uptake in other vascular beds, and cardiovascular
risk factors.
R01 HL78667, and NIH/NIBIB R01 EB009638 [to Dr. Fayad]) and b
Laboratories and FoxHollow Technologies. Dr. Myers was supported by t
by the NIHR Cambridge Biomedical Research Center and an Internationa
Burke, Ms. Pinto, Mr. Klimas, Mr. Hargreaves, and Dr. Dansky are
Hailman and Mr. Bolognese were associated with Merck Research Lab
associated with Novartis Institutes for Biomedical Research Inc. and Cyte
as Guest Editor for this paper.Manuscript received May 1, 2011; revised manuscript received August 1, 201M E T H O D S
Patient recruitment. We used a multicenter recruit-
ment and imaging strategy. Five hospital sites
underwent study training by the core imaging
laboratory, Mount Sinai Hospital (Table 1). A
multicenter nature was chosen in the hope of
increasing patient recruitment and to develop a
method for secure online PET image transfer. After
institutional review board approval, 30 patients with
intermittent claudication were recruited for the
trial. Eligible patients were aged between 40 and 85
years, had 1 or more de novo atherosclerotic lesions
of at least 60% stenosis in the common or superficial
femoral artery, and had been referred for therapeu-
tic peripheral artery atherectomy for treatment of
their PAD. Patients were excluded if they had any
of the following: recent cardiovascular event (3
months), critical limb ischemia, total occlusion of
the target vessel, a glucose level 200
mg/dl on the day of imaging, a body mass
index 40 kg/m2, or type 1 diabetes.
hese criteria were chosen to avoid the
elay of treatment and/or avoid the un-
ecessary introduction of variables that are
nown to affect standard uptake values of
DG. Medical history was obtained from
ach patient on the day of enrollment in
he study, including presence of cardiovas-
ular risk factors. All patients underwent
18F-FDG-PET/CT imaging within the 2
weeks before atherectomy of their symp-
tomatic lesion.
Image acquisition. Patients underwent an
18F-FDG-PET/CT scan on either a General Electric
Lightspeed (GE Healthcare, Waukesha, Wisconsin)
or Siemens Biograph PET/CT scanner (Siemens
Healthcare, Malvern, Pennsylvania) (Table 1) for an
estimated effective radiation dose of 10 mSv. All
subjects fasted for at least 8 h before the intravenous
injection of 370 MBq of 18F-FDG. After a 90-min
circulation time, patients underwent PET/CT imag-
ing beginning with a noncontrast CT for attenuation
correction and anatomic coregistration. A 90-min
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40circulation time was chosen because previous repro-
ducibility studies of FDG uptake in the femoral
arteries was performed using this time frame (13).
This method allows for more patient comfort than
earlier studies in which up to a 3-h circulation time
was used. In addition, PET scanning of the peripheral
arteries was then performed in 2-dimensional mode
with the inferior border of the imaging field at the
patella, and PET scanning of the carotid arteries was
performed in 3-dimensional mode using a previously
validated acquisition and reconstruction protocol
(13,14). Anonymized images from all sites were sent
to the core imaging laboratory for reading. In addi-
tion, a conventional peripheral angiogram, identifying
the plaque for atherectomy, was supplied in all cases
for coregistration with the PET/CT images.
Image analysis. PET/CT image analysis was per-
formed at the core laboratory by a reader blinded to
all patient demographic characteristics using a Xe-
leris 2.0 PET/CT workstation (GE Healthcare).
Arterial FDG uptake was confirmed in 3 orthogo-
nal planes. The degree of uptake was assessed on
every axial image by drawing a region of interest
around the artery to obtain the maximum standard
uptake value. This value was then corrected for
blood pool by dividing by the average standard
uptake value in a nearby vein to obtain a tissue-to-
background ratio (TBR). For whole artery analysis,
the TBRs for all axial images across the entire
arterial region were averaged to obtain a single TBR
value for that region. To measure the “target” lesion
TBR, the plaque of interest was first identified on
the angiogram, and the corresponding axial slices
on the PET image were identified using anatomic
landmarks. Because the TBR for every axial image
had previously been recorded, the TBRs for the
slices corresponding to the lesion were averaged
into 1 target lesion TBR value for comparison with
pathology and biomarkers.
Tissue collection and processing. Plaque tissue was
xcised at atherectomy using the SilverHawk cath-
ter (FoxHollow Technologies, Redwood City,
alifornia) by 1 designated cardiologist at each site.
Table 1. Sites Participating in This Multicenter Study
Study Site P
Mount Sinai Medical Center, New York, New York GE Disco
Memorial Hospital, Jacksonville, Florida GE Disco
Sacred Heart Hospital, Pensacola, Florida Siemens
William Beaumont Hospital, Royal Oak, Michigan GE Disco
St. Vincent’s Medical Center, Jacksonville, Florida Siemensmmediately after excision, plaque tissue was rinsedith sterile saline and transferred to cryogenic vials
or freezing in liquid nitrogen. For each plaque, its
ocation angiogram was recorded and sent to the
ore laboratory along with images of the angiogram
erformed before the procedure. Tissue samples
ere shipped on dry ice and stored at 80°C until
rocessing.
Frozen plaque tissue samples were homogenized
nd analyzed using immunohistochemical staining.
lthough histology was not performed on the
xcised plaques in this study, an example of histol-
gy from a plaque sample obtained using the
ilverHawk extraction device is shown in Figure 1.
n this study, however, the frozen plaque samples
ere ground with a mortar and pestle and homoge-
ized with ultrasound-based acoustic disruption (Co-
aris E200; Covaris, Inc., Woburn, Massachusetts) in
hosphate buffer solution with 1% CHAPS (a
ulfobetaine-type zwitterionic detergent). After 2
ounds of homogenization followed by centrifugation
3000 rpm for 30 min), the supernatants were com-
ined and mixed, and the resulting plaque extracts
ere frozen at 80°C until analysis by immunoassay
s described in the following text. We have found a
trong correlation between cluster of differentiation 68
CD68) content measured by using immunoassay and
he measurement of the area of CD68 staining by
sing immunohistochemistry (E. Hailman, unpub-
ished data, January 2007), and in the current study
acrophage content of the tissue extracts was mea-
ured by using a CD68 immunoassay. Quality control
amples derived from plaque extracts were included in
ach run.
Statistical analysis. Correlations between lesion-
specific maximum TBR and CD68 content were
assessed using Pearson’s correlation coefficient test-
ing. Correlations between maximum TBR values in
different arterial territories were similarly assessed.
For analysis of CD68 content, the data were first
assessed for normality, and if needed, a log trans-
formation was applied. Pearson correlations were
then used to check for associations between TBR
and CD68 level. The relationship of TBR in each
T Scanner
No. of Patients Enrolled
(No. of Patients Included in Analysis)
LS 16-slice 2 (2)
LS 4-slice 9 (6)
graph Duo 2-slice 7 (7)
LS 16-slice 9 (6)
graph Duo 2-slice 1 (0)ET/C
very
very
Bio
veryarterial territory with known cardiovascular risk
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41factors was performed using the unpaired Student t
test for categorical variables and Pearson correla-
tions for linear variables. For comparison between
peripheral and carotid artery territory FDG uptake,
TBRs in the peripheral arteries were pooled and
compared with the pooled carotid artery TBRs
(with equal weighting for each analyzed slice) using
the paired Student t test. For all analyses, p  0.05
was considered significant.
R E S U L T S
Thirty patients were enrolled in the study. Nine
patients were subsequently excluded from final
analysis because of poor PET/CT image quality
(n  4), atherectomy procedures rescheduled outside
of the 2-week period after imaging (n  2), and
ineligibility based on inclusion/exclusion criteria (n 
3). Twenty-one patients with complete datasets for
the peripheral arteries (femoral imaging, immunohis-
tochemical staining, and biomarkers) were included in
the study. The included population was 57% male
with a mean  SD age of 67  10 years. More than
75% of patients had a history of hyperlipidemia, statin
use, or coronary artery disease (CAD) (Table 2).
Before imaging, subjects had a mean fasting glucose
level of 113  27 mg/dl. Imaging of the femoral
arteries began a mean of 97 11 min after 18F-FDG
injection. Carotid imaging datasets from 6 subjects
were excluded because of poor image quality.
A total of 29 specimens were obtained from the
21 patients (range 1 to 3 specimens per patient)
with adequate imaging. The lesion-specific TBR
was not significantly different from the TBR in the
entire artery ipsilateral to the excised lesion. TBR
values ranged from 1.02 to 1.51 (mean 1.17 
0.16). CD68 values ranged from 0.004 to 13.468
(mean 3.92  3.43). There was no correlation
between lesion TBR and lesion CD68 values (r 
0.21) (Figs. 2 and 3).
Assessing associations between patient sex and
TBR values found that the mean TBR in the
peripheral arteries was significantly higher in males
compared with females (1.31  0.24 vs. 1.14 
0.09; p  0.05). This difference in the sexes did not
reach statistical significance in the carotid arteries
(1.93  0.24 vs. 1.82  0.05; p  0.35). Compar-
ing TBR values between different arterial regions
revealed that the mean carotid artery TBR was 45%
higher than the mean peripheral artery TBR (p 
0.05) (Fig. 4). High correlations were observed
between right and left arterial TBR values in thefemoral (r  0.95; p  0.0001) and carotid (r 
0.64; p  0.05) (Fig. 5) territories.
D I S C U S S I O N
Results from several pre-clinical and clinical studies
indicate that FDG accumulates in macrophages of
atherosclerotic plaques (3,6,15), with correlations
between vascular FDG uptake measurements and
quantitative immunohistological measurements of
macrophage content of surgically excised carotid
plaque (6,7). There are also reports linking carotid
FDG uptake with expression of several pro-
inflammatory genes expressed in carotid atheroscle-
rosis, including CD68, cathepsin K, and glucose
Figure 1. Plaque Histology of SilverHawk Atherectomy Specime
Representative histology sample of atherosclerotic plaque from a p
nary study extracted by using the SilverHawk technique (FoxHollow
nologies, Redwood City, California) stained with hematoxylin and e
(H&E), cluster of differentiation 68 (CD68; for macrophages), Elastica
Gieson ([EVG]; for connective tissue), and Gomori’s Trichrome (for s
muscle cells [SMC]).
Table 2. Patient Characteristics
Characteristic Value
Age (yrs) 67.9 9.7
Body mass index (kg/m2) 28.7 3.6
Diabetes 12 (57)
Statin use 20 (95)
Smoking history 15 (71)
Smoking within 90 days 4 (19)
Hyperlipidemia 19 (90)
CAD* 16 (76)
Transient ischemic attack 9 (43)
Values are mean  SD or n (%). *Patients were considered to have a history
of coronary artery disease (CAD) if they had a history of myocardial infarction,ns
relimi-
Tech-
osin
-van
moothpercutaneous coronary intervention, or coronary artery bypass graft.
l
m
max TBR v
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 1 , 2 0 1 2
J A N U A R Y 2 0 1 2 : 3 8 – 4 5
Myers et al.
18F-FDG Uptake and Peripheral Plaque Inflammation
42transporter 1 (8,10). However, in our study, signif-
icant correlation between FDG uptake and CD68
content of catheter-excised peripheral plaque was
not observed. Several factors may explain the lack of
concordance between this study and the other
studies discussed here. These factors include: 1) the
lack of a true link between femoral plaque FDG
uptake and macrophage content; 2) unreliable
coregistration between PET imaging data and exact
ocation of excised plaque; and 3) variance in the
ethods of lesion extraction. Additional factors in-
CD68 Versus TBR
of cluster of differentiation 68 (CD68) (after log transformation
lity) and mean of the maximum target-to-background ratios (max
excised femoral lesions. CD68 values from the excised lesion as a
f macrophage content showed no signiﬁcant correlation to the
alues in the lesion (r  0.21; p  0.05).
Figure 3. PET/CT Images in Subjects With High Versus Low CD6
Axial computed tomography (CT), positron emission tomography (P
tively, in the region of the excised lesion for subjects with (A) a low
[about 1 SD below the mean]) and (B) a higher CD68 value (CD68
CD68 content and mean of the maximum target-to-background ratios (clude the multicenter nature of this study, which may
have led to variability in reporting of culprit lesion data
(marking of the angiogram for the location of index
plaque), along with the acquisition of PET/CT stud-
ies by different technicians on different types of
PET/CT machines. Finally, only 21 of the 30 patients
imaged had a complete dataset that could be analyzed
(because of poor image quality or failure to meet
eligibility criteria, as detailed earlier), all of which may
have presented a potential bias.
There are several issues related to the choice of
arterial bed that may have had an impact on the
correlation analysis. The small size of peripheral
arteries will increase the influence of partial volume
error as the artery size approaches the innate reso-
lution of PET. The larger size of the carotid arteries
would tend to reduce this effect and allow for
quantification (16). Additionally, the significant
difference in TBR between the peripheral and
carotid arteries seen in this study as well as in
previous studies (6,7,13) suggests that the degree of
inflammation in symptomatic peripheral athero-
sclerosis is lower than in carotid atherosclerosis.
This finding may be due to differences in their
pathogenesis: femoral lesions are more likely to be
composed of fibrous and calcified material, which
accumulates less FDG than lipid-rich, inflamed
plaque (17,18). Calcification in the peripheral and
carotid arteries was in fact a common finding on the
CT images in this study, and previous studies do
alues
and fused PET/CT images are shown from left to right, respec-
luster of differentiation 68 (CD68) value (CD68 value of 1.08
e of 1.4 [about 1 SD above the mean]). No correlation betweenFigure 2.
Correlation
for norma
TBR) in the
measure o8 V
ET),
er c
valumax TBR) in the excised lesions was found (p  0.05).
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43reveal that inflammation and calcification rarely
coexist in the same plaque (5,9). Both the TBR and
CD68 values in this study were low in general.
Therefore, although several previous studies have
shown correlations between FDG uptake and mac-
rophage content in the carotid arteries, the smaller
size and lower levels of inflammation in peripheral
artery lesions may be 2 biological reasons why such
correlations were not apparent in our study.
Difficulty in coregistration of imaging data and
histology of the excised plaque could also have con-
tributed to the lack of correlation between lesion-
specific TBR and CD68. In the carotid study by
Tawakol et al. (6) involving a correlation of FDG
signal with macrophage staining, the authors were
able to precisely align imaging and histological data.
Methodologic aspects of our study precluded such
accuracy. Specifically, manually identifying the exact
location of the excised lesions on the PET/CT images
was difficult, raising the possibility of ascribing the
wrong section of artery on PET for analysis. In addition,
catheter-based tissue extraction yielded multiple, thin
strips of tissue rather than a single intact specimen,
limiting our ability to maintain orientation of the tissue
sample, which would have allowed more precise align-
ment with imaging data. In future studies, rigid coregis-
tration of the angiogram and PET/CT datasets would
help to resolve this issue, and modifications of the
atherectomy procedure might be necessary to provide
proper registration of tissue data with imaging data.
Our methods for plaque biomarker measurement
were also different from previous FDG-PET stud-
Figure 4. TBR in Different Arterial Regions
Mean of the max TBR in different arterial regions. Error bars indicat
than the max TBRs in any peripheral region (*p  0.05). CFA  car
ation as in Figure 2.ies. Because gross tissue structure cannot be pre-served after the SilverHawk procedure, our tissue
samples were homogenized, and CD68 was mea-
sured by using immunoassay.
Despite these potential sources of variability,
several significant findings were seen in this study.
The strong correlation between the FDG uptake in
1 SD. Max TBRs of the carotid arteries were signiﬁcantly higher
femoral arteries; SFA  superﬁcial femoral arteries; other abbrevi-
Figure 5. TBRs of Right Versus Left Arterial Regions
Correlations of mean of the max TBR in the right versus left (A) SFA
carotid arteries. Signiﬁcant, high correlations between right and left
in these regions demonstrate the global nature of atherosclerotic ine 
otidand (B)
arteries
ﬂamma-tion. Abbreviations as in Figures 2 and 4.
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44the right and left superficial femoral arteries and
right and left carotid arteries reinforces the global
nature of atherosclerosis. FDG uptake in the pe-
ripheral arteries was significantly higher in males
than in females, suggesting more inflammation in
their atherosclerotic plaques. This finding is consis-
tent with previous work demonstrating that FDG
uptake in the carotid arteries is also higher in males
than in females (9). These findings may indicate
that the degree of plaque inflammation may be a
contributor to the known increased cardiovascular
risk in males. Because this endpoint involved only
the imaging portion of the study, the ability to
replicate previous findings in a multicenter study
setting is encouraging. The lack of correlation
between other cardiovascular risk factors and pe-
ripheral artery FDG uptake may be due to the small
sample size in many subgroups; in larger studies,
significant correlations have been noted between
several risk factors and FDG uptake in the carotid
arteries (9). In particular, the small sample size (n
6) of subjects without hyperlipidemia, CAD, and
not taking statins will have meant that such analyses
were underpowered.
C O N C L U S I O N S
As the field of atherosclerotic plaque imaging with
FDG PET/CT continues to evolve, it is important toSM, Strauss HW. Association of tors, and biomarknique. Although this study did not find a correlation
between FDG uptake in symptomatic peripheral ar-
tery atherosclerosis and underlying CD68 content, we
did highlight previously unknown challenges posed by
imaging peripheral vessels with PET/CT. The impor-
tance of accurate image:tissue coregistration was also
demonstrated, as imprecision in this study likely con-
tributed to the negative result.
More positively, this study was able to show the
feasibility of multicenter PET/CT vascular imaging
studies by reproducing several findings previously
demonstrated only at expert, single-center imaging
facilities. These include noting significantly higher
FDG uptake in males compared with females,
demonstrating strong correlations in FDG uptake
between left and right vessels, and measuring higher
FDG uptake in the carotid arteries than in the
femoral vessels.
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